Cell-specific regulation of gene expression is important for maintaining cortical excitatory/inhibitory balance. In this issue of Neuron, Vuong et al. (2018) reveal an unlikely role for a broadly expressed RNA binding protein, Rbfox1, in protecting inhibitory transmission in the hippocampus.
circuits is robust and resistant to genetic and environmental perturbation. In fact, several molecules required for neurite targeting in mice and other organisms have been identified and penetrance of the mistargeting phenotype is often quite low (Tessier-Lavigne and Goodman, 1996) . The developed CRISPR technique is well suited to identify redundant pathways, as creation of double mutants would simply require that two guide RNAs be introduced simultaneously. In fact, this study already successfully uses this approach: while single CRISPRmediated mutations in the Ryk co-receptors Fzd4 or Fzd5 do not produce a phenotype, simultaneous mutations in both Fzd genes result in an ectopic OPL.
This study demonstrates the advantages of combining diverse methods to study a complex problem: the authors combine a detailed description of retina development together with transcriptome data, a CRISPR-based mutagenesis strategy, and an in vitro assay to understand how two types of neurons-rod photoreceptor and rod bipolar cellsmake proper connections within the OPL. Given the enormous amount of data generated by their transcriptome comparisons, the authors wisely focus on receptors and secreted molecules and identify several candidates that, when mutated, disrupt formation of the outer retina. Their initial success suggests that this approach will identify additional wiring molecules. Expanding the candidate list beyond cell surface receptors and secreted proteins could identify the upstream factors (i.e., transcription factors) that ensure that the receptors and secreted proteins that contribute to proper wiring are uniquely expressed in a single cell type, and could also identify the downstream factors that function within the cell to ensure proper growth and/or wiring after reception of the secreted ligand. This transcriptional dataset, together with the ability to generate and assay functional mutations in the retina within just a few days, promises to contribute significantly to our understanding of the molecular mechanisms that direct the formation of functional neuronal circuits.
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Despite different genetic origins and involvement in distinct signaling pathways, 30% of these disease-linked genes are predicted to impact inhibitory interneuron function (Siehr and Noebels, 2016) . In this issue of Neuron, Vuong et al. (2018) add to the richness of cell-specific mechanisms essential for maintaining cortical excitatory/inhibitory balance. They show how the multi-functional, broadly expressed RNA binding protein Rbfox1 maintains normal inhibitory transmission in the hippocampus by protecting the mRNA of a critical synaptic gene expressed in inhibitory neurons against microRNA-mediated degradation ( Figure 1 ). This cytoplasmic function of Rbfox1 adds to its role as a critical regulator of RNA processing of a host of genes involved in cortical development and implicated in epilepsies and autism spectrum disorders (Lee et al., 2016) .
The importance of cell-specific processing of RNA in expanding the coding capacity of genes in specific tissues, and in regulating gene expression, is extensively documented. Alternative premRNA splicing-a form of RNA processing regulated by nuclear RNA binding proteins-generates pools of mRNA splice isoforms from individual genes that can vary greatly depending on the function and the state of the cell (Raj and Blencowe, 2015) . Other forms of RNA processing involve cytoplasmically localized RNA binding proteins and are mediated via the 3 0 untranslated regions (3 0 UTRs) of key genes to modulate mRNA stability (Lee et al., 2016) . Whole-transcriptome analyses from massively parallel sequencing across different brain regions, cell types, and disease states leave no doubt of the richness and importance of cell-specific RNA processing to brain function (Raj and Blencowe, 2015) . Global genetic deletion of cell-specific RNA binding proteins in mice often results in lethality, pointing to a critical role of these factors early in development (Ule et al., 2005) . Knowing the cell-specific signals and proteins that control RNA processing is key to understanding the mechanisms that generate unique cell-specific patterns of mRNA isoforms and that control expression levels to influence cell-specific functions. However, the biological consequences of the majority of individual RNA binding events within genes and the actions of individual RNA variants that continue to grow in number are largely unknown. Moreover, the cellular determinants of cell-specific actions of RNA binding proteins are incompletely understood.
Cell-specific RNA binding proteins, such as the Rbfox protein family, recruit transcriptional machinery in the cell nucleus to control the choice of alternatively spliced exons of target genes by the spliceosome, and other isoforms of RNA binding proteins can localize to, and act within, the cytoplasm. In the cytoplasm, RNA binding proteins bind 3 0 UTRs of key mRNAs to regulate mRNA stability and protein expression levels. Genomewide mapping of RNA binding factor binding in different tissues gives us a road map to begin to build a comprehensive picture of the cell-specific protein-RNA interactions that regulate RNA processing and protein function (Licatalosi et al., 2008; Ule et al., 2005; Yeo et al., 2009) . Nuclear splicing factors direct exon inclusion or exclusion during alternative splicing of pre-mRNAs typically via intronic binding sites close to intron-exon boundaries. Cytoplasmic-acting RNA binding proteins, including Rbfox, NOVA, CELF, and MBNL family members (Lee et al., 2016; Licatalosi et al., 2008; Shi and Manley, 2015; Van Nostrand et al., 2016; Wang et al., 2015) , which can regulate alternative splicing in the nucleus, bind the 3 0 UTRs of several mRNAs to influence mRNA stability. In this issue of Neuron, Vuong et al. (2018) isolate the 3 0 UTRdependent actions of Rbfox1 in hippocampus, from Rbfox1 effects on alternative splicing, to reveal its importance as a cytoplasmic inhibitor of microRNA (miR)-dependent degradation of Vamp1 mRNA. Building from an earlier study in which they dissect the functions of Rbfox1 according to cytoplasmic and nuclear sites of action (Lee et al., 2016) , Vuong et al. (2018) cleverly connect the dots among multiple players (miR-9, Vamp1 mRNA, and cytoplasmic Rbfox1 protein) to show how cis-and trans-acting factors influence one gene to maintain inhibitory synaptic output in the hippocampus (Figure 1) .
Intrigued by the susceptibility of mice lacking Rbfox1 in the brain and nervous system (Rbfox1-Nestin-cKO) to spontaneous and induced seizures, Vuong et al. (2018) The cytoplasmic isoform of Rbfox1 binds to (U)GCAUG motifs in the 3 0 untranslated region (UTR) of Vamp1 mRNA. Here we illustrate one of several Rbfox1 binding sites in the 3 0 UTR that protects Vamp1 mRNA from miR-9-mediated degradation. Vamp1 is expressed in inhibitory hippocampal neurons, but not excitatory neurons. In the absence of cytoplasmic Rbfox1, miR-9 binds the 3 0 UTR of Vamp1 promoting degradation, reducing Vamp1 protein levels and inhibitory synaptic transmission. Schematic is based on findings reported in Vuong et al. (2018). cytoplasmic Rbfox1 in maintaining excitation/inhibitory balance in cortical networks. They restricted their analysis to high-confidence mRNA targets of Rbfox1 expressed in hippocampus, particularly those whose expression levels exhibit the greatest change in Rbfox1-deficient hippocampus compared to wild-type. Vuong et al. (2018) identified >1,000 differentially expressed genes in the hippocampus of Rbfox1-Nestin-cKO mice as compared to wild-type controls by RNA sequencing. From this initial larger list of Rbfox1 gene targets, they zeroed in on a small subset of 15 genes previously identified by iCLIP from both the soluble nucleotide fraction (i.e., processed mRNAs ready for export into the cytoplasm) and the cytoplasmic fraction (i.e., exported mRNAs) (Lee et al., 2016) and after applying additional criteria to enrich for Rbfox1-3 0 UTR interactions. Of these 15 Rbfox1 target genes, 11 were downregulated in the hippocampus of Rbfox1-Nestin-cKO mice, suggesting that Rbfox1 somehow protects these mRNAs from degradation. The top three Rbfox1 hits, as defined by the greatest fold decrease in gene expression in the hippocampus of Rbfox1-Nestin-cKO mice, were Vamp1/synaptobrevin1, adenyl cyclase 1 (adcy1), and a basic leucine zipper transcription factor (Hlf). Vuong et al. (2018) chose to focus on Vamp1/ synaptobrevin1, a protein that they also showed in this study is expressed in inhibitory, but not in excitatory, neurons of the hippocampus.
Vamp1/synaptobrevin1, a v-SNARE, is involved in synaptic vesicle priming and promotes evoked vesicle fusion. Vuong et al. (2018) confirmed Vamp1 as a key target of Rbfox1 by showing profound reductions in Vamp1 mRNA and protein levels in hippocampus, but not in the cerebellum of neuronal-restricted Rbfox1-Nestin-cKO mice compared to wild-type. The electrophysiological analyses of synaptic events in hippocampal recording from Rbfox1-Nestin-cKO and wild-type mice were also consistent with reduced inhibitory transmission, including release probability, in the absence of Rbfox1. The specificity of Rbfox1 to influence Vamp1 expression levels in hippocampus, but not other brain regions that also express Rbfox1, invokes the need for additional, cell-specific factors to explain the actions of Rbfox1. Moreover, Vamp1 expression is restricted to inhibitory, but not excitatory, neurons of the hippocampus. What cellular factors act on Vamp1 mRNA to promote its degradation in hippocampal inhibitory neurons in the absence of Rbfox1? Vuong et al. (2018) identify the culprit as the microRNA miR-9, which, in the absence of cytoplasmic Rbfox1, binds its microRNA response element in the 3 0 UTR of Vamp1 mRNA, thereby promoting Vamp1 mRNA degradation (Figure 1) . Thus, cytoplasmic Rbfox1 prevents miR-9-mediated degradation of Vamp1 mRNA, presumably via occlusion, by binding to an Rbfox motif adjacent to the miR-9 microRNA response element in the 3 0 UTR of Vamp1 (Figure 1 ). Although the 3 0 UTR of Vamp1 contains several Rbfox1 binding motifs that influence expression to varying degrees, Vuong et al. (2018) show that the 3 0 most (U)GCAUG Rbfox1 binding site located adjacent to the miR-9 element has the greatest influence on Vamp1 mRNA stabilization.
This elegant study by Vuong et al. (2018) defines a cellular mechanism critical for maintaining inhibitory signaling and excitation/inhibitory balance in hippocampal circuits, but it also illustrates how cell-specific control of RNA processing can be achieved by the action of a relatively broadly expressed protein, Rbfox1, when its actions, in turn, depend on certain other cell-specific factors. The report by Vuong et al. (2018) provokes a number of interesting questions. For example, are there cellular mechanisms that act to regulate the opposing actions of Rbfox1 to miR-9? The Black lab has shown that the relative abundance of cytoplasmic-tonuclear Rbfox isoforms (generated from alternative splicing of Rbfox1 pre-mRNA) is influenced by neuronal activity (Lee et al., 2009) . The Rbfox1 splice isoform in the nucleus regulates alternative premRNA splicing of a number of target genes, whereas a different splice isoform of Rbfox1 that localizes to the cytoplasm targets 3 0 UTRs of mRNAs. If the level of cytoplasmic Rbfox1 is limiting, might neuronal activity impact the level of cytoplasmic Rbfox1 protein available to protect Vamp1 mRNA from miR-9-mediated degradation?
Our understanding of the where, when, and how of RNA processing is currently incomplete, but the landscape is changing rapidly. Vuong et al. (2018) illustrate the value of studying RNA processing in specific neurons of known function-the physiologically relevant cellular context-and, as they show, cell-specific mechanisms can involve the coordinated actions of proteins with surprisingly broad expression patterns.
